ID Consult

Preventing recurrent staphylococcal skin and soft tissue infection


 

References

In summary, recurrent SSTI is common, especially among young children. The burden of colonization appears related to both the risk for recurrent disease and the risk for transmission within the household. Reducing colonization is valuable for decreasing the incidence of recurrent SSTI both for the individual as well as the household members. The current strategies demonstrate modest success, but as many as 30%-40% of patients will continue to have recurrent SSTI. Education about the early signs of infection, early evaluation of SSTI, and appropriate management (topical treatment, incision and drainage, or systemic antibiotics) are successful strategies for limiting progression to invasive staphylococcal disease.

Dr. Pelton is chief of pediatric infectious disease and coordinator of the maternal-child HIV program at Boston Medical Center. Dr. Yildirim is a fellow in pediatric infectious disease and an epidemiologist, at Boston Medical Center. To comment, e-mail Dr. Pelton and Dr. Yildirim at pdnews@frontlinemedcom.com.

Pages

Recommended Reading

Low-risk actinic keratosis? No such thing
MDedge Family Medicine
Topical efinaconazole permeates nail to infection
MDedge Family Medicine
Certolizumab achieves sustained skin improvement in psoriatic arthritis
MDedge Family Medicine
Dupilumab advances for severe atopic dermatitis
MDedge Family Medicine
Itchy abdominal rash
MDedge Family Medicine
Adapalene/benzoyl peroxide + doxycycline outscores oral isotretinoin
MDedge Family Medicine
Occipital scalp papules in a teenage boy
MDedge Family Medicine
Pearce-ings: Why should dermatologists have all the fun?
MDedge Family Medicine
New law will speed sunscreen ingredient approval
MDedge Family Medicine
Managing molluscum contagiosum: ‘The great imitator’
MDedge Family Medicine